[HTML][HTML] Changing epidemiology, global trends and implications for outcomes of NAFLD

VWS Wong, M Ekstedt, GLH Wong, H Hagström - Journal of hepatology, 2023 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …

Towards precision medicine in non-alcoholic fatty liver disease

SM Francque - Reviews in Endocrine and Metabolic Disorders, 2023 - Springer
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of lipid laden
vacuoles in hepatocytes, occurring in the context of visceral adiposity, insulin resistance and …

NAFLD prevalence and severity in overweight and obese populations

SMA Francque, E Dirinck - The Lancet Gastroenterology & …, 2023 - thelancet.com
See Articles page 31 Vedolizumab is a humanised anti-α4β7 integrin that regulates
intestinal inflammation by inhibiting the migration of intestinal T lymphocytes. Vedolizumab …

Screening for NAFLD—current knowledge and challenges

R Forlano, G Sigon, BH Mullish, M Yee, P Manousou - Metabolites, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver
function tests worldwide, with an estimated prevalence ranging between 19–46% in the …

[HTML][HTML] From NAFLD to HCC: Advances in noninvasive diagnosis

Q Xu, M Feng, Y Ren, X Liu, H Gao, Z Li, X Su… - Biomedicine & …, 2023 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) has gradually become one of the major liver
health problems in the world. The dynamic course of the disease goes through steatosis …

Medical imaging in the assessment of cardiovascular disease risk

JMA Alcantara, F Idoate, I Labayen - Current Opinion in Clinical …, 2023 - journals.lww.com
Although body composition can be assessed by simple techniques, these calculations can
provide erroneous results and conclusions, requiring complex interpretations when diverse …

Hepatic Involvement across the Metabolic Syndrome Spectrum: Non-Invasive Assessment and Risk Prediction Using Machine Learning

A Solomon, CR Cipăian, MO Negrea… - Journal of Clinical …, 2023 - mdpi.com
Metabolic-dysfunction-associated steatotic liver disease (MASLD) and metabolic syndrome
(MetS) are inextricably linked conditions, both of which are experiencing an upward trend in …

The epidemiology and characteristics of patients with diabetes with or without NASH: a systematic review

KK Aldossari - African Health Sciences, 2023 - ajol.info
Introduction: NASH or “Non-alcoholic Steatohepatitis” is related to non-alcoholic fatty liver
disease (NAFLD). The simultaneous occurrence of NASH and type 2 diabetes is common …

Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine–a case study of diabetes and nonalcoholic fatty liver disease

Y Bao, X Han, D Liu, Z Tan, Y Deng - Frontiers in immunology, 2022 - frontiersin.org
Metabolic syndrome mainly includes obesity, type 2 diabetes (T2DM), alcoholic fatty liver
(NAFLD) and cardiovascular diseases. According to the ancient experience philosophy of …

Upper gut heat shock proteins HSP70 and GRP78 promote insulin resistance, hyperglycemia, and non-alcoholic steatohepatitis

G Angelini, L Castagneto-Gissey, S Salinari… - Nature …, 2022 - nature.com
A high-fat diet increases the risk of insulin resistance, type-2 diabetes, and non-alcoholic
steato-hepatitis. Here we identified two heat-shock proteins, Heat-Shock-Protein70 and …